Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.37% |
$37,090
$37.09 p/Share
|
Dec 11
2024 |
|
IONQ
|
Peter Hume Chapman
President and CEO |
SELL
Open market or private sale
|
Direct | 13,106 Reduced 3.07% |
$389,641
$29.73 p/Share
|
Dec 11
2024 |
|
IONQ
|
Thomas G. Kramer
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,780 Reduced 1.04% |
$290,661
$29.72 p/Share
|
Dec 11
2024 |
|
IONQ
|
Rima Alameddine
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 21,337 Reduced 3.6% |
$634,349
$29.73 p/Share
|
Dec 11
2024 |
|
ADCT
|
Redmile Group, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100,000 Added 0.75% |
$305,000
$3.05 p/Share
|
Dec 11
2024 |
|
ADCT
|
Redmile Group, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 0.0% |
$305,000
$3.05 p/Share
|
Dec 11
2024 |
|
ARES
|
Ryan Berry
Chief Mktg. & Strategy Officer |
SELL
Open market or private sale
|
Direct | 14,357 Reduced 5.8% |
$2,586,557
$180.16 p/Share
|
Dec 11
2024 |
|
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 192,266 Reduced 0.0% |
$2,932,056
$15.25 p/Share
|
Dec 11
2024 |
|
PLTR
|
Stephen Andrew Cohen
Director |
SELL
Open market or private sale
|
Direct | 450,000 Reduced 99.87% |
$31,788,000
$70.64 p/Share
|
Dec 11
2024 |
|
APGE
|
Carl Dambkowski
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,540 Reduced 1.73% |
$223,867
$49.31 p/Share
|
Dec 11
2024 |
|
GKOS
|
Gilbert H Kliman |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.82% |
$288,020
$144.01 p/Share
|
Dec 11
2024 |
|
SBTX
|
Brian Dorsey
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 71.35% |
$186,450
$12.43 p/Share
|
Dec 11
2024 |
|
UONE
|
Kristopher Simpson
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 9,210 Reduced 100.0% |
$9,854
$1.07 p/Share
|
Dec 11
2024 |
|
ACIW
|
Scott W Behrens
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 60,749 Reduced 11.09% |
$3,383,111
$55.69 p/Share
|
Dec 11
2024 |
|
PLSE
|
Robert W Duggan |
BUY
Open market or private purchase
|
Direct | 56,054 Added 0.13% |
$957,402
$17.08 p/Share
|
Dec 11
2024 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 750 Added 0.0% |
$6,255
$8.34 p/Share
|
Dec 11
2024 |
|
LPSN
|
Bruce Edward Hansen
Director |
SELL
Open market or private sale
|
Direct | 84,944 Reduced 100.0% |
$72,202
$0.85 p/Share
|
Dec 11
2024 |
|
S
|
Tomer Weingarten
President, CEO |
SELL
Open market or private sale
|
Direct | 82,116 Reduced 7.88% |
$1,938,758
$23.61 p/Share
|
Dec 11
2024 |
|
UONE
|
Peter Thompson
CFO/EVP |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 31.19% |
$107,000
$1.07 p/Share
|
Dec 11
2024 |
|
GSAT
|
Timothy Evan Taylor
VP, Finance & Operations |
SELL
Open market or private sale
|
Indirect | 3,500,000 Reduced 0.0% |
$7,770,000
$2.22 p/Share
|
Dec 11
2024 |
|
PBAXU
|
Yk Bioventures Opportunities Gp I, LLC |
SELL
Open market or private sale
|
Indirect | 1,343,801 Reduced 0.0% |
$107,504
$0.08 p/Share
|
Dec 11
2024 |
|
WSC
|
Graeme Parkes
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 2,900 Reduced 3.83% |
$107,329
$37.01 p/Share
|
Dec 11
2024 |
|
NRDS
|
Samuel Yount
Chief Business Officer |
SELL
Open market or private sale
|
Indirect | 65,167 Reduced 0.0% |
$898,652
$13.79 p/Share
|
Dec 11
2024 |
|
HOOD
|
Baiju Bhatt
Director |
SELL
Open market or private sale
|
Indirect | 186,514 Reduced 0.0% |
$7,111,778
$38.13 p/Share
|
Dec 11
2024 |
|
TEM
|
Theodore Leonsis |
SELL
Open market or private sale
|
Indirect | 400,000 Reduced 0.0% |
$16,463,999
$41.16 p/Share
|
Dec 11
2024 |
|
TEM
|
James William Rogers
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 83,025 Reduced 26.42% |
$3,511,127
$42.29 p/Share
|
Dec 11
2024 |
|
TEM
|
Erik Phelps
EVP & Chief Admin & Legal Off |
SELL
Open market or private sale
|
Direct | 82,109 Reduced 26.04% |
$3,473,210
$42.3 p/Share
|
Dec 11
2024 |
|
TEM
|
Ryan Fukushima
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 120,000 Reduced 10.65% |
$5,073,600
$42.28 p/Share
|
Dec 11
2024 |
|
TEM
|
Jennifer A Doudna |
SELL
Open market or private sale
|
Direct | 1,183 Reduced 3.07% |
$49,461
$41.81 p/Share
|
Dec 11
2024 |
|
TEM
|
David R Epstein |
SELL
Open market or private sale
|
Direct | 620 Reduced 2.17% |
$25,922
$41.81 p/Share
|
Dec 11
2024 |
|
TEM
|
Andrew Polovin
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 51,504 Reduced 17.31% |
$2,178,619
$42.3 p/Share
|
Dec 11
2024 |
|
WRBY
|
Steven Clive Miller
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 7,016 Reduced 3.71% |
$167,331
$23.85 p/Share
|
Dec 11
2024 |
|
DHHCU
|
James M Pirrello
Interim CEO |
BUY
Open market or private purchase
|
Direct | 50,000 Added 50.0% |
$250,000
$5.0 p/Share
|
Dec 11
2024 |
|
SFM
|
Douglas Gregory Rauch
Director |
SELL
Open market or private sale
|
Direct | 700 Reduced 6.05% |
$104,222
$148.89 p/Share
|
Dec 11
2024 |
|
RNA
|
W. Michael Flanagan
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 21.94% |
$858,480
$35.77 p/Share
|
Dec 11
2024 |
|
DHHCU
|
Michael P. Nieri
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 400,000 Added 28.14% |
$2,000,000
$5.0 p/Share
|
Dec 11
2024 |
|
DHHCU
|
Michael P. Nieri
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 500,000 Added 0.0% |
$2,500,000
$5.0 p/Share
|
Dec 11
2024 |
|
DBX
|
Andrew Houston
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 137,499 Reduced 0.0% |
$4,131,844
$30.05 p/Share
|
Dec 11
2024 |
|
RBLX
|
Mark Reinstra
Chief Legal Off. & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.77% |
$300,000
$60.0 p/Share
|
Dec 11
2024 |
|
RBLX
|
Manuel Bronstein
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 44,888 Reduced 7.26% |
$2,693,728
$60.01 p/Share
|
Dec 11
2024 |
|
ALHC
|
John E Kao
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 90,000 Reduced 0.0% |
$1,048,500
$11.65 p/Share
|
Dec 11
2024 |
|
SHAK
|
Katherine Irene Fogertey
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 642 Reduced 2.05% |
$88,358
$137.63 p/Share
|
Dec 11
2024 |
|
NCNO
|
Jeff Horing |
SELL
Open market or private sale
|
Indirect | 1,167,424 Reduced 0.0% |
$42,832,786
$36.69 p/Share
|
Dec 11
2024 |
|
AGL
|
Silvana Battaglia
Director |
BUY
Open market or private purchase
|
Direct | 25,062 Added 27.48% |
$50,374
$2.01 p/Share
|
Dec 11
2024 |
|
CWEN
|
Brian R. Ford |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 10.93% |
$25,890
$25.89 p/Share
|
Dec 11
2024 |
|
CWEN
|
Brian R. Ford |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.28% |
$27,590
$27.59 p/Share
|
Dec 11
2024 |
|
COCO
|
Corey Baker
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 4.32% |
$74,560
$37.28 p/Share
|
Dec 11
2024 |
|
COCO
|
Jane Prior
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 2,474 Reduced 1.86% |
$91,587
$37.02 p/Share
|
Dec 11
2024 |
|
COCO
|
Martin F Roper
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.38% |
$182,650
$36.53 p/Share
|
Dec 11
2024 |
|
COCO
|
Martin F Roper
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 0.0% |
$547,800
$36.52 p/Share
|
Dec 11
2024 |